We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Expression Kit Designed for High-throughput Automated Usage

By LabMedica International staff writers
Posted on 04 Oct 2015
A newly released kit for gene expression measurement was designed for high-throughput use with 384-well microplates.

The Affymetrix (Santa Clara, CA, USA) QuantiGene Singleplex Assay does not require nucleic acid purification, reverse transcription, or PCR amplification. More...
Packaged for use on 384-well microplates, the assay is readily adaptable for automated high-throughput screening.

The manufacturer recommends using the QuantiGene assay for screening of compounds in drug discovery, for biomarker validation, and in siRNA (small, inhibiting RNA) knockdown studies. The assay works with a wide range of sample types, including heavily degraded and cross-linked RNA in FFPE (formalin fixed paraffin embedded) samples and RNA circulating in blood.

“This new, automation-friendly 384-well assay format fits with current workflows because cells are most commonly cultured in 384-well plates for high-throughput screening,” said Brian McLucas, product manager at Affymetrix. “Furthermore, the limiting step with qPCR is RNA purification, which is completely avoided with QuantiGene assays. Gene expression-based high-throughput screening of hundreds of thousands of compounds can be carried out in just weeks.”

Related Links:
Affymetrix


New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
All-in-One Molecular System
AIO M160
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.